Details for Patent: 5,290,815
✉ Email this page to a colleague
Summary for Patent: 5,290,815
Title: | Treatment of inflammation and allergy |
Abstract: | The present invention provides a new medical use for the phenethanolamine compound 4-hydroxy-.alpha..sup.1 -[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol and physiologically acceptable salts and solvates thereof in the treatment of inflammation, allergy and allergic reaction. |
Inventor(s): | Johnson; Malcolm (Orwell, GB2), Whelan; Clifford J. (Buntingford, GB2) |
Assignee: | Glaxo Group Limited (London, GB2) |
Application Number: | 07/799,001 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,290,815
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,290,815
International Family Members for US Patent 5,290,815
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2024789 | ⤷ Try a Trial | |||
European Patent Office | 0416925 | ⤷ Try a Trial | |||
European Patent Office | 1078629 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |